Radiopharm Theranostics Ltd
RAD 301
pancreatic ductal adenocarcinoma
Date
TBD
Phase 1 readout · Date TBD estimated
What's at stake
Phase 1 trial results for RAD 301 in pancreatic ductal adenocarcinoma are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“During the half year, eight of the planned nine patients were dosed, with initial data from the first six confirming favourable safety.”